MARGARET R. SPITZ, M.D., MPH
Medical Practice in Houston, TX
License number
Texas F2030
Category
Medical Practice
Type
Public Health & General Preventive Medicine
Address
Address
1515 Holcombe Blvd., Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about MARGARET R. SPITZ at radaris.comName
Address
Phone
761 Trees Dr, Cedar Hill, TX 75104
Organization information
See more information about MARGARET R. SPITZ at bizstanding.comMargaret R Spitz MD
1155 Pressler St, Houston, TX 77030
Industry:
Services-Misc
Owner:
Margaret Spitz (Owner)
Professional information
Margaret Ruth Spitz M.P.H., Houston TX
Specialties:
Preventive Medicine, Public Health & General Preventive Medicine, Dermatology, Hematology & Oncology, Medical Oncology
Work:
M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030
Education:
University Of The Witwatersrand (1966)
Dr. Margaret R Spitz, Houston TX - MD (Doctor of Medicine)
Specialties:
Public Health & General Preventive Medicine
Address:
1515 Holcombe Blvd SUITE 189, Houston 77030
(713) 792-6161 (Phone)
(713) 792-6161 (Phone)
Languages:
English
Hospitals:
1515 Holcombe Blvd SUITE 189, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
University of The Witwatersrand/Faculty of Health Sciences
University of The Witwatersrand/Faculty of Health Sciences
Methods For Assessing Cancer Susceptibility To Carcinogens In Tobacco Products
US Patent:
2010017, Jul 8, 2010
Filed:
Jun 11, 2007
Appl. No.:
12/304298
Inventors:
Randa A. El-Zein - League City TX, US
Matthew B. Schabath - Houston TX, US
Carol J. Etzel - Houston TX, US
Mirtha S. Lopez - Porter TX, US
Margaret R. Spitz - Houston TX, US
Matthew B. Schabath - Houston TX, US
Carol J. Etzel - Houston TX, US
Mirtha S. Lopez - Porter TX, US
Margaret R. Spitz - Houston TX, US
Assignee:
The Board of Regents, of the University of Texas System - Austin TX
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention demonstrates the differential sensitivity of PBLs from lung cancer patients and healthy controls to NNK-induced genetic damage. The data provide convincing evidence that the preferred CBMN assay is a robust test for detection of this sensitivity and yields results that are a good predictor of, for example, lung cancer risk. The simplicity, rapidity, and sensitivity of the CBMN test make it a valuable tool for screening and, for example, prioritizing potential cases for early detection of the disease.